共 50 条
- [41] 2D nanostructures: Potential in diagnosis and treatment of Alzheimer's diseaseBIOMEDICINE & PHARMACOTHERAPY, 2024, 170Tufail, SabaSherwani, Mohammad AsifShamim, ZahidAbdullahGoh, Khang WenAlomary, Mohammad N.Ansari, Mohammad AzamAlmosa, Abdulaziz AbdullahMing, Long ChiauAbdullah, Amar Daud IskandarKhan, Farheen BadrealamAl Menhali, AsmaMirza, SameerAyoub, Mohammed Akli
- [42] Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington's DiseaseJOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (24) : 9934 - 9954Buerli, Roland W.Luckhurst, Christopher A.Aziz, OmarMatthews, Kim L.Yates, DawnLyons, Kathy. A.Beconi, MariaMcAllister, GeorgeBreccia, PerlaStott, Andrew J.Penrose, Stephen D.Wall, MichaelLamers, MariekeLeonard, PhilipMueller, IlkaRichardson, Christine M.Jarvis, RebeccaStones, LizHughes, SamanthaWishart, GrantHaughan, Alan F.O'Connell, CatherineMead, TaniaMcNeil, HannahVann, JulieMangette, JohnMaillard, MichelBeaumont, VahriMunoz-Sanjuan, IgnacioDominguez, Celia
- [43] CKD-506, a Novel Inhibitor of Histone Deacetylase 6 (HDAC6) Has a Therapeutic Potential in Rheumatoid Arthritis and Inflammatory Bowel DiseaseARTHRITIS & RHEUMATOLOGY, 2017, 69Shin, JieunHa, NinaBae, DaekwonSuh, Dong-HyeonJang, Yu JinShon, SehuiBaek, Ji-YeonJun, Jae HyunLee, Yong JaeLee, ChangsikKim, Sei-HwanYu, HosungChoi, Young IlRyu, Keun HoLee, Soung-MinSong, Yeong WookSeo, Su K.Kim, Seong Kon
- [44] Histone Deacetylase Inhibitor Improves the Dysfunction of Hippocampal Gamma Oscillations and Fast Spiking Interneurons in Alzheimer's Disease Model MiceFRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 14Takasu, KeikoNiidome, KazukiHasegawa, MinoruOgawa, Koichi
- [45] Defining the Therapeutic Potential of Class Specific Histone Deacetylase Inhibitions in an In Vitro Neuroinflammation Model of Parkinson's DiseaseIRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (SUPPL 2) : 53 - 53Krakoski, NatalieO'Keeffe, Gerard
- [46] In silico identification of 2-oxo-1,3-thiazolidine derivatives as novel inhibitor candidate of class II histone deacetylase (HDAC) in cervical cancer treatmentARABIAN JOURNAL OF CHEMISTRY, 2019, 12 (02) : 272 - 288Tambunan, Usman S. F.Parikesit, Arli A.Ghifari, Abi S.Satriyanto, Cipta Prio
- [48] Development of a GSK-3 inhibitor as a potential treatment for Alzheimer's diseaseEUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 33 - 33Del Ser, T.Andres, M. V.Vericat, J. A.Martinez, A.Medina, M.
- [49] Combined Treatment with 177Lu-DOTATOC and Histone Deacetylase Inhibitor s on SSTR2 Expression and Uptake in in vivoEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S334 - S334Bakr, H.Al-Awar, A.Forssell-Aronsson, E.
- [50] A phase 2 study of the histone deacetylase (HDAC) inhibitor mocetinostat in patients with urothelial carcinoma (UC) and inactivating alterations of acetyltransferase genes.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Hahn, Noah M.Picus, JoelBambury, Richard MartinPal, Sumanta KumarHart, Lowell L.Grivas, PetrosMilowsky, Matthew I.Alva, Ajjai ShivaramSonpavde, GuruMortazavi, AmirBellmunt, JoaquimGuancial, Elizabeth A.Gupta, SumatiChao, Richard C.Collier, Mary A.Christensen, JamesChen, IsanRosenberg, Jonathan E.